PE20010303A1 - Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido - Google Patents
Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acidoInfo
- Publication number
- PE20010303A1 PE20010303A1 PE2000000565A PE0005652000A PE20010303A1 PE 20010303 A1 PE20010303 A1 PE 20010303A1 PE 2000000565 A PE2000000565 A PE 2000000565A PE 0005652000 A PE0005652000 A PE 0005652000A PE 20010303 A1 PE20010303 A1 PE 20010303A1
- Authority
- PE
- Peru
- Prior art keywords
- acid medium
- labil
- inhibitor
- presentation
- proton pump
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19925710A DE19925710C2 (de) | 1999-06-07 | 1999-06-07 | Neue Zubereitung und Darreichungsform enthaltend einen säurelabilen Protonenpumpenhemmer |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010303A1 true PE20010303A1 (es) | 2001-03-09 |
Family
ID=7910295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000000565A PE20010303A1 (es) | 1999-06-07 | 2000-06-07 | Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR024310A1 (de) |
CO (1) | CO5160296A1 (de) |
DE (1) | DE19925710C2 (de) |
MY (1) | MY138975A (de) |
PE (1) | PE20010303A1 (de) |
TW (1) | TWI255720B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2430816C (en) | 2000-12-07 | 2012-05-15 | Altana Pharma Ag | Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
WO2002045692A1 (en) * | 2000-12-07 | 2002-06-13 | Altana Pharma Ag | Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient |
DE10061138C1 (de) * | 2000-12-07 | 2002-08-14 | Byk Gulden Lomberg Chem Fab | Pharmazeutische Zubereitung in Form eines Saftes enthaltend einen säurelabilen Wirkstoff |
JP2004514737A (ja) * | 2000-12-07 | 2004-05-20 | アルタナ ファルマ アクチエンゲゼルシャフト | 酸分解性活性成分を含有する迅速に崩壊する錠剤 |
DE10061136C1 (de) * | 2000-12-07 | 2002-10-24 | Byk Gulden Lomberg Chem Fab | Schnell zerfallende Tablette enthaltend einen säurelabilen Protonenpumpenhemmer |
DE10061137B4 (de) * | 2000-12-07 | 2016-10-06 | Takeda Gmbh | Neue pharmazeutische Zubereitung |
DE10061135C1 (de) * | 2000-12-07 | 2002-11-07 | Byk Gulden Lomberg Chem Fab | Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff |
SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
BR0212950A (pt) * | 2001-09-28 | 2004-10-26 | Mcneil Ppc Inc | Formas de dosagens compósitas tendo uma porção inserida |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
CA2490142A1 (en) * | 2002-07-03 | 2004-01-15 | Abbott Laboratories | Liquid dosage forms of proton pump inhibitors |
DE10244129B4 (de) * | 2002-09-23 | 2006-04-20 | Iongate Biosciences Gmbh | H+-K+-ATPase-Assay |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
ME00524B (me) | 2003-03-10 | 2011-10-10 | Astrazeneca Ab | Novi postupak za dobijanje roflumilasta |
TW200503783A (en) * | 2003-04-11 | 2005-02-01 | Altana Pharma Ag | Oral pharmaceutical preparation for proton pump antagonists |
WO2006097456A1 (en) | 2005-03-16 | 2006-09-21 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2725924C3 (de) * | 1977-06-08 | 1980-11-06 | Hobeg Hochtemperaturreaktor-Brennelement Gmbh, 6450 Hanau | Verfahren zur Herstellung kugelförmiger Teilchen aus niedrigschmelzenden organischen Substanzen |
DE3524572A1 (de) * | 1985-07-10 | 1987-01-15 | Thomae Gmbh Dr K | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
JP2681373B2 (ja) * | 1988-07-18 | 1997-11-26 | 塩野義製薬株式会社 | 徐放性製剤の製造法 |
-
1999
- 1999-06-07 DE DE19925710A patent/DE19925710C2/de not_active Expired - Fee Related
-
2000
- 2000-05-30 CO CO00040091A patent/CO5160296A1/es unknown
- 2000-05-30 MY MYPI20002403A patent/MY138975A/en unknown
- 2000-06-07 PE PE2000000565A patent/PE20010303A1/es not_active Application Discontinuation
- 2000-06-07 TW TW089111052A patent/TWI255720B/zh not_active IP Right Cessation
- 2000-06-07 AR ARP000102825A patent/AR024310A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR024310A1 (es) | 2002-09-25 |
CO5160296A1 (es) | 2002-05-30 |
DE19925710A1 (de) | 2000-12-14 |
TWI255720B (en) | 2006-06-01 |
DE19925710C2 (de) | 2002-10-10 |
MY138975A (en) | 2009-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20010303A1 (es) | Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido | |
UA74339C2 (uk) | Форма для введення, що включає інгібітор протонної помпи у вигляді окремих одиниць, та спосіб їх одержання | |
CY1120513T1 (el) | Υψηλης συμπυκνωσης συνθεση μινοξιδιλης | |
ES2542728T3 (es) | Composiciones farmacéuticas que tienen la biodisponibilidad deseable | |
RU2005110945A (ru) | Капсулы, содержащие водные наполняющие композиции, стабилизированные производным циклодекстрина | |
ES2155043B1 (es) | Composiciones farmaceuticas comprendiendo acido pirimidin-5-il(3r, 5s)-3,5-dihidroxihept-6-enoico o una sal suya, su estabilizacion con sal fosfato tribasico y su preparacion. | |
AP2397A (en) | Matrix for sustained, invariant and independent release of active compounds. | |
PE3296A1 (es) | Composicion oral conteniendo un mucoadhesivo | |
JP2006328089A (ja) | 安定な局所レチノイド組成物 | |
CO5180575A1 (es) | Composiciones antibacterianas orales de lupulona hidrogenda estable | |
PE20081365A1 (es) | Formulaciones topicas para administracion local que contienen indoxacarb | |
CO5221123A1 (es) | Desodorante con pequenas particulas de oxido de zinc | |
PT2116243E (pt) | Composição de gel para tratamento de micoses | |
BR0007360A (pt) | Composição de liberação controlada | |
AR055090A1 (es) | Una presentacion farmaceutica de forma de dosificacion de liberacion modificada que comprende un inhibidor de la enzima ciclooxigenasa | |
PE20041024A1 (es) | Sistema de liberacion controlada | |
AR038681A1 (es) | Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua | |
NO20055601L (no) | Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer | |
NO820319L (no) | Antimykotisk middel i form av stifter og med hoey virksom stoff frigjoering | |
CO5380014A1 (es) | Formulacion farmaceuticas para la administracion oral o topica de compuestos hidrofobicos que no frma emulsion | |
PE20040545A1 (es) | Formulaciones parasiticidas que comprenden benzoimidazoles o salicilanilidas en combinacion con lactonas macrociclicas | |
MY143793A (en) | Non-tabletted, chewable, individually dosed administration forms | |
ES2460967T3 (es) | Método para la prevención de la degradación de una sustancia térmicamente inestable | |
ES2530874T3 (es) | Formulaciones de depósito de corta duración | |
CO5160318A1 (es) | Composicion precursora para preparar un dialitico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |